Chester County News and Community Website
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has released its financial results for the second quarter ending June 30, 2024, alongside significant business updates that highlight the company’s progress in clinical …
Savara Inc. Reports Strong Q2 2024 Results and Positive IMPALA-2 Trial Outcomes Read More
LANGHORNE, PA — In a significant advancement for patients suffering from autoimmune Pulmonary Alveolar Proteinosis (aPAP), Savara Inc. has revealed promising outcomes from its IMPALA-2 Phase 3 clinical trial. The …
Savara Inc. Announces Breakthrough in aPAP Treatment with IMPALA-2 Trial Success Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) announced that its management team will participate in a fireside chat at the Jefferies Global Healthcare Conference. The event is scheduled for June …
Savara Inc. to Present at Jefferies Global Healthcare Conference Read More LANGHORNE, PA — Biopharmaceutical company Savara Inc. (Nasdaq: SVRA) disclosed its financial outcomes for the first quarter ended March 31, 2024, while casting an optimistic glance towards its pipeline’s progress …
Savara Inc. Eyes Future Growth with Ongoing IMPALA-2 Trial and Strategic Investments Read More